Spruce Biosciences, Inc. SPRB
NASDAQ · United States · Health Technology
$45.71+0.94 (+2.10%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -6.68 | -5.79 | -15.4% | $0 | — | +7.2%$46.41→$49.77 |
| Q1 2026 | 2026-05-13 | -8.94 | -7.32 | -22.1% | — | — | +4.1%$56.67→$59.00 |
| Q4 2025 | 2026-03-09 | -9.58 | -9.41 | -1.8% | — | — | +12.4%$55.87→$62.79 |
| Q3 2025 | 2025-11-10 | -14.58 | -15.56 | +6.3% | — | — | -11.3%$127.00→$112.66 |
| Q4 2024 | 2025-04-15 | -42.75 | -15.38 | -178.0% | — | — | — |
| Q2 2024 | 2024-08-12 | -16.50 | -23.75 | +30.5% | — | — | — |
| Q1 2024 | 2024-05-13 | -21.00 | -21.00 | 0.0% | — | — | — |
| Q4 2023 | 2024-03-13 | -17.25 | -28.75 | +40.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.